Pelvic fracture adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From February 2004 to June 2026, FDA received 7,657 adverse event reports that record the MedDRA preferred term Pelvic fracture. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 467 reports in the 12 months to June 2026 and 447 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 78 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Pelvic fracture name as a suspect product, in order of name
Drug	Class	Reports with this term
Abatacept	Selective T cell costimulation modulator	57
Aclasta		98
Actemra	Interleukin-6 receptor antagonist	49
Actonel	Bisphosphonate	34
Alendronate sodium	Bisphosphonate	83
Ambrisentan	Endothelin receptor antagonist	29
Amlodipine	Calcium channel blocker	26
Apixaban	Factor Xa inhibitor	39
Avonex	Interferon beta	117
Azathioprine	Purine antimetabolite	32
Boniva		57
Carbidopa levodopa	Aromatic amino acid	64
Ciclosporin		33
Cordarone		28
Cosentyx	Interleukin-17A antagonist	25
Dexamethasone	Corticosteroid	48
Dianeal Low Calcium		42
Dianeal Low Calcium Peritoneal Dialysis Solution with Dextrose		59
Duodopa		54
Dupixent	Interleukin-4 receptor alpha antagonist	53
Eliquis	Factor Xa inhibitor	72
Enbrel	Tumor necrosis factor blocker	254
Entresto	Angiotensin 2 receptor blocker	28
Evenity		60
Evista	Estrogen Agonist/Antagonist	53
Fentanyl	Opioid agonist	33
Forteo	Parathyroid hormone analog	496
Fosamax	Bisphosphonate	266
Fosamax Plus D		35
Human immunoglobulin g	Human immunoglobulin G	33
Humira		388
Ibrance	Kinase inhibitor	30
Imbruvica	Kinase inhibitor	78
Imuran	Purine antimetabolite	30
Inflectra	Tumor necrosis factor blocker	28
Kisqali	Kinase inhibitor	37
Lenalidomide	Thalidomide analog	40
Letrozole	Aromatase inhibitor	32
Lyrica		47
Methotrexate	Folate analog metabolic inhibitor	136
Methotrexate sodium	Folate analog metabolic inhibitor	57
Mirtazapine		43
Nexium	Proton pump inhibitor	59
Nuplazid	Atypical antipsychotic	32
Omeprazole	Proton pump inhibitor	38
Opsumit	Endothelin receptor antagonist	35
Orencia	Selective T cell costimulation modulator	47
Oxazepam	Benzodiazepine	32
OxyContin	Opioid agonist	39
Pomalyst	Thalidomide analog	44
Pradaxa	Direct thrombin inhibitor	55
Prednisolone	Corticosteroid	50
Prednisone	Corticosteroid	79
Prolia	RANK ligand inhibitor	376
Ramipril	Angiotensin converting enzyme inhibitor	27
Reclast	Bisphosphonate	40
Remicade	Tumor necrosis factor blocker	85
Revlimid	Thalidomide analog	204
Rinvoq	Janus kinase inhibitor	141
Risedronate sodium	Bisphosphonate	36
Rituximab	CD20-directed cytolytic antibody	64
Skyrizi	Interleukin-23 antagonist	82
Sulfasalazine	Aminosalicylate	57
Synthroid	l-Thyroxine	41
Tecfidera		50
Teriparatide	Parathyroid hormone analog	37
Tiotropium bromide	Anticholinergic	32
Tracleer	Endothelin receptor antagonist	46
Tramadol		32
Truvada	Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	51
Tymlos		50
Tysabri	Integrin receptor antagonist	76
Vedolizumab	Integrin receptor antagonist	38
Vioxx		25
Viread	Hepatitis B virus nucleoside analog reverse transcriptase inhibitor	28
Xeljanz	Janus kinase inhibitor	199
Zoledronic acid	Bisphosphonate	32
Zometa		45

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 53 pharmacologic classes with 25 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Pelvic fracture name, in order of name
Class	Reports with this term
Aminosalicylate	57
Angiotensin 2 receptor blocker	86
Angiotensin converting enzyme inhibitor	55
Anti-epileptic agent	36
Anticholinergic	57
Antimalarial	36
Antirheumatic agent	32
Aromatase inhibitor	44
Aromatic amino acid	98
Atypical antipsychotic	91
Benzodiazepine	103
beta-Adrenergic blocker	69
Bisphosphonate	526
Calcium channel blocker	28
CD20-directed cytolytic antibody	108
Cholinesterase inhibitor	35
Corticosteroid	237
Direct thrombin inhibitor	57
Endothelin receptor antagonist	138
Erythropoiesis-stimulating agent	32
Estrogen Agonist/Antagonist	53
Factor Xa inhibitor	121
Folate analog metabolic inhibitor	193
gamma-Aminobutyric acid A receptor positive modulator	34
Hepatitis B virus nucleoside analog reverse transcriptase inhibitor	40
HMG-CoA reductase inhibitor	43
Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	60
Human immunoglobulin G	36
Insulin analog	73
Integrin receptor antagonist	116
Interferon beta	138
Interleukin-17A antagonist	25
Interleukin-23 antagonist	82
Interleukin-4 receptor alpha antagonist	57
Interleukin-6 receptor antagonist	69
Janus kinase inhibitor	372
Kinase inhibitor	214
l-Thyroxine	47
Nonsteroidal anti-inflammatory drug	77
Nucleoside metabolic inhibitor	43
Opioid agonist	199
Parathyroid hormone analog	533
Potassium channel blocker	36
Prostacycline vasodilator	44
Proteasome inhibitor	27
Proton pump inhibitor	145
Purine antimetabolite	62
RANK ligand inhibitor	391
Selective T cell costimulation modulator	104
Serotonin reuptake inhibitor	39
Thalidomide analog	292
Tumor necrosis factor blocker	441
Vascular endothelial growth factor inhibitor	31

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Pelvic fracture, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Pelvic fracture
Age	Reports	Share
Under 2	1	under 0.1%
2 to 11	4	0.1%
12 to 17	15	0.2%
18 to 44	260	3.4%
45 to 64	1,214	15.9%
65 to 74	1,282	16.7%
75 and over	2,225	29.1%
Age not given	2,656	34.7%

Sex of the patient in the reports that record Pelvic fracture
Sex	Reports	Share
Female	5,878	76.8%
Male	1,333	17.4%
Unknown or not given	446	5.8%

Age and sex are as the report gives them. 59.2% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Pelvic fracture: adverse event reports that record this term. https://reportedreactions.com/reaction/pelvic-fracture/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 1 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Pelvic fracture mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page